Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection

被引:18
|
作者
Kocabora, M. Selim [1 ]
Durmaz, Sahan [1 ]
Kandemir, Nilay [1 ]
机构
[1] Vakif Gureba Educ & Res Hosp, Ophthalmol Clin, Istanbul, Turkey
关键词
Central serous chorioretinopathy; Intravitreal triamcinolone acetonide; Retinal vein occlusion; Anticardiolipin antibodies;
D O I
10.1007/s00417-008-0932-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
This report describes a case of central serous chorioretinopathy following intravitreal triamcinolone acetonide injection. A 42-year-old man presented with a 4-month history of decreased visual acuity (0.4) in his left eye. The left eye demonstrated macular edema due to branch retinal vein occlusion. Triamcinolone acetonide 4 mg/ 0.1 mL was injected intravitreally to treat the macular edema. Pigmentary retinal discoloration, retinal pigment epithelium leakage and a slight neurosensorial detachment with cystoid macular edema at the temporal macula were present prior to intravitreal triamcinolone injection. Three weeks after injection, visual acuity had decreased to 0.2 and metamorphopsies appeared in the left eye. A sharply demarcated serous macular elevation and a progressively increasing hyperfluorescence of the pre-existing leakage point led to the diagnosis of "exacerbation of the pre-existing asymptomatic central serous chorioretinopathy" following intravitreal triamcinolone injection. Macular elevation spontaneously resolved by the 4th month post-injection. At the 6th month, the patient experienced recurrence of a small serous detachment at the temporal macula. Central serous chorioretinopathy exacerbation may arise as a complication of intravitreal triamcinolone acetonide injection.
引用
收藏
页码:1783 / 1786
页数:4
相关论文
共 50 条
  • [1] Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection
    M. Selim Kocabora
    Sahan Durmaz
    Nilay Kandemir
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2008, 246 : 1783 - 1786
  • [2] INTRAVITREAL BEVACIZUMAB INJECTION FOR CENTRAL SEROUS CHORIORETINOPATHY
    Lim, Su Jin
    Roh, Mi In
    Kwon, Oh Woong
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (01): : 100 - 106
  • [3] Intravitreal bevacizumab injection for chronic central serous chorioretinopathy
    Li Xiu-juan
    Zhang Jin-song
    CHINESE MEDICAL JOURNAL, 2010, 123 (15) : 2145 - 2147
  • [4] Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy
    Chung, Yoo-Ri
    Lee, Su Jeong
    Song, Ji Hun
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [5] Intravitreal Bevacizumab in Central Serous Chorioretinopathy
    Jamil, Ahmad Zeeshan
    Rahman, Fawad Ur
    Iqbal, Kashif
    Ansari, Harris Muzammil
    Iqbal, Wasirn
    Mirza, Khurram Azam
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2012, 22 (06): : 363 - 366
  • [6] Intravitreal bevacizumab for chronic central serous chorioretinopathy
    Niegel, M. F.
    Schrage, N. F.
    Christmann, S.
    Degenring, R. F.
    OPHTHALMOLOGE, 2008, 105 (10): : 943 - 945
  • [7] The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy
    Lim, Ji Won
    Kim, Min Uk
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (07) : 969 - 974
  • [8] The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy
    Ji Won Lim
    Min Uk Kim
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 969 - 974
  • [9] Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy
    Goncalves, Annelise Nicotti
    Messias, Andre
    Chaves, Leandro
    de Azeredo Bastos, Thais Marino
    Jorge, Rodrigo
    DOCUMENTA OPHTHALMOLOGICA, 2022, 145 (03) : 211 - 219
  • [10] Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy
    Annelise Nicotti Gonçalves
    André Messias
    Leandro Chaves
    Thaís Marino de Azeredo Bastos
    Rodrigo Jorge
    Documenta Ophthalmologica, 2022, 145 : 211 - 219